UNSPSC 51181608: Levothyroxine or thyroxine or triiodothyronine

This classification denotes a generic primary tumor tnm finding with the molecular formula C15H11I4NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q51BO43MG4, chemically known as 3,5,3,5-tetraiodothyronine but generally known as levothyroxine, which bears US NIH Compound Identifier 853. European Medicines Agency schedules Levothyroxine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02917MIG. SMILES: C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N.

UNSPSC 51181608 Levothyroxine or thyroxine or triiodothyronine is a Commodity code for synthetic thyroid hormone medications used to treat hypothyroidism and related thyroid disorders. State and local governments purchase these medications primarily through public health departments, correctional facilities, school districts, and transit authorities to support employee health plans and inmate or student medical services. The medications are supplied as oral tablets or capsules in various dosages and are typically procured through competitive bidding or cooperative purchasing agreements that establish unit pricing for ongoing dispensing.

The source provides no recent state or local contract opportunities under this code.